25 September 2017

KWM represents Cardihab on its spin-out from CSIRO and Series A financing round

King & Wood Mallesons (KWM) has advised Cardihab, an innovative smartphone app used for remote management of patients who have experienced a heart-related health scare, on its spin-out from CSIRO and Series A financing round.
 
Cardihab benefited from CSIRO’s ON Accelerator program which is helping to make science market-ready to allow technologies to deliver national benefit faster, as well as the HCF Slingshot program.
 
The KWM team was led by Partner Scott Bouvier and supported by Senior Associate Anthony Boogert. 

Commenting on the transaction, Scott Bouvier said; “KWM has a longstanding relationship with CSIRO, and we are delighted to have advised Cardihab on this significant transaction which supports CSIRO’s vision of commercialising scientific technologies that create tangible and high-impact solutions in the health sector.”
 
Anthony Boogert added; “Cardihab is expected to deliver strong economic benefits, which will be reinvested into new science to support the innovation cycle.”
 
Cardihab is the first CSIRO invention to be financially backed by Uniseed – a fund backed by University of Queensland, University Of Sydney, University of Melbourne and UNSW – contributing $500,000 to a $1.35 million fundraising.


Media contact

Share on LinkedIn Share on Facebook Share on Twitter Share on Google+
    You might also be interested in

    KWM has acted on Woodside Petroleum Limited’s pro rata accelerated renounceable entitlement offer

    14 February 2018

    KWM has been recognised as the Most Popular Overall Law Employer in the 2018 AFR Top 100 Graduate Employers Rankings.

    12 February 2018

    King & Wood Mallesons advised Paladin Energy Limited and its administrators KPMG, on Paladin’s complex balance sheet restructure.

    08 February 2018

    KWM has advised By-Health Co.on the acquisition of Australian probiotic market leader Life-Space Group.

    05 February 2018